A Decline in Metabotropic Glutamate mGlu3 Receptor Levels Is Associated With Amyloid Plaques in Alzheimer's Disease and Is Detectable in Serum During Mild Cognitive Impairment

Documenti analoghi

• Alzheimer's disease is associated with changes in the metabotropic glutamate mGlu3 receptor expression but not with SNPs in the GRM3 gene
  di: Eugenia Olivera, et al.
  Pubblicazione: (2025)
• Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder
  di: Maria Meringolo, et al.
  Pubblicazione: (2025)
• Nicotinic Acetylcholine Receptor‐Mediated Metabotropic Signalling in Human Microglia
  di: Lydia J. Bye, et al.
  Pubblicazione: (2025)
• Multiplexing FSCV and iGluSnFR3 Sensors Reveals Adenosine Transiently Inhibits Stimulated Dopamine and Glutamate Release
  di: Kailash Shrestha, et al.
  Pubblicazione: (2025)
• The Glutamate/ GABA ‐Glutamine Cycle: Insights, Updates, and Advances
  di: Jens V. Andersen
  Pubblicazione: (2025)